BIODEP Showcases Probiotic Innovations at 2025 SupplySide Global in the U.S.

2025 11/04

From October 29 to 30, 2025 (local time), the globally anticipated 2025 SupplySide Global – International Exhibition of Natural, Healthy, and Innovative Ingredients – was grandly held in Las Vegas, USA. As a leading enterprise in China’s probiotics industry, BIODEP made a remarkable appearance on this international stage, showcasing China’s innovative achievements and technological strength in the probiotics field to the world.

Chinese Strength on the International Stage

Recognized as the trendsetter of the global health industry, SupplySide Global is one of the largest and most influential international exhibitions in the fields of natural extracts, nutraceutical ingredients, and dietary supplements. This year’s exhibition gathered nutritional ingredient suppliers, functional food and dietary supplement brands, research institutions, and biotech enterprises from over 100 countries and regions worldwide to discuss the latest trends and future developments in the health industry.

Focus on Probiotic Innovation: Technological Strength Supports Global Layout

At the exhibition, BIODEP highlighted multiple innovative achievements in probiotics, including:

· The anti-aging AKK strain derived from centenarians in Bama (Akkermansia muciniphila AKK-LTA21F2);

· Breast milk-derived strains for infant health (Lactobacillus reuteri FPHC2951, Bifidobacterium breve FPHC4024);

· Kefir-derived strains with high EPS (exopolysaccharide) production (Lactobacillus helveticus LZ-R-5,Lactobacillus plantarum T1,Lactobacillus paracasei GL1).

These innovations demonstrate advanced probiotic R&D capabilities with Chinese characteristics. Additionally, BIODEP has developed unique formulations such as oil-droplet and crystal-bead delivery systems, which enhance strain stability and absorption efficiency while adapting to diverse food and beverage applications—fully reflecting its technological prowess in probiotic innovation.

These achievements are built on BIODEP's solid R&D foundation and industrialization capabilities. The company's microbial bank houses approximately 2,000 strains, with over 40 commercialized strains, and leads in key technologies such as Lactobacillus plantarum viability preservation. Currently, BIODEP has achieved a hundred-ton-level production capacity for probiotic raw powder, with an annual output of 100 tons of high-activity freeze-dried powder. It operates multiple production bases and R&D centers globally, continuously supporting its international market expansion.

Expanding International Cooperation to Promote Probiotic Globalization

Leveraging the SupplySide Global platform, BIODEP connected with global industry leaders and professional audiences to explore potential collaborations. Its products are already exported to over 20 countries and regions, including developed markets such as the United States, Canada, and Spain.

Through this exhibition, BIODEP gained first-hand insights into the latest trends and consumer demands in the global probiotics market, providing valuable input for optimizing its market strategy. The company will continue to focus on R&D and innovation in core probiotic technologies.

BIODEP is committed to advancing Chinese probiotic technology onto the world stage and contributing Chinese wisdom to the global health industry.

Previous:Spotlight on Anaheim: BIODEP Makes Its Mark at the World's Premier Natural Products Event

Next:BIO · Probiotic Gift | Decoding the "Molecular Puzzle" of Yogurt Texture!